Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for 300016.SZ and 80,000+ other tickers.
See exactly how 300016.SZ's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 300016.SZ and 80,000+ other tickers.
Beijing Beilu Pharmaceutical Co., Ltd., established in 1992 and headquartered in Beijing, China, operates within the pharmaceutical industry. The company is primarily involved in the research, development, production, and commercialization of diverse medicinal products. Its offerings notably include specialized drugs like contrast agents, treatments for central nervous system conditions, and oral medications designed for diabetes. Additionally, Beilu Pharmaceutical also ventures into the manufacturing of precision medicine.
No recent news available.